These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8644989)

  • 21. Managed competition, antitrust, and the Clinton health reform plan: too modest a proposal.
    Kopit WG
    Healthspan; 1993 Nov; 10(10):21-4. PubMed ID: 10130836
    [No Abstract]   [Full Text] [Related]  

  • 22. Competition policy in health care markets: navigating the enforcement and policy maze.
    Gaynor M
    Health Aff (Millwood); 2014 Jun; 33(6):1088-93. PubMed ID: 24841882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Revised DOJ and FTC policy statements offer more options for physician joint ventures.
    Busey RC
    Healthc Financ Manage; 1996 Nov; 50(11):79-80, 82. PubMed ID: 10162353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Managed care and antitrust--a guide for provider-sponsored PPOs.
    Hershey D
    Trustee; 1993 Sep; 46(9):12-4. PubMed ID: 10128227
    [No Abstract]   [Full Text] [Related]  

  • 25. Accountable Care Organizations and Antitrust Enforcement: Promoting Competition and Innovation.
    Feinstein DL; Kuhlmann P; Mucchetti PJ
    J Health Polit Policy Law; 2015 Aug; 40(4):875-86. PubMed ID: 26124309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consumer issues and threats to health care market reform.
    Pietzsch PM
    Manag Care Q; 1996; 4(4):49-57. PubMed ID: 10162550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Staying within those antitrust "safety zones".
    Walker LM
    Med Econ; 1994 May; 71(10):52, 55, 59. PubMed ID: 10133949
    [No Abstract]   [Full Text] [Related]  

  • 28. Antitrust enforcement guidelines for providers in the wake of health care reform.
    Zoric S
    J Health Hosp Law; 1993 Dec; 26(12):359-64, 358. PubMed ID: 10138597
    [No Abstract]   [Full Text] [Related]  

  • 29. Texas' new physician collective bargaining statute: helping to fatten physicians' wallets and make patients' leaner.
    Mayo TW; King JP
    Health Care Law Mon; 1999 Sep; ():3-13. PubMed ID: 10623065
    [No Abstract]   [Full Text] [Related]  

  • 30. Preferred provider organizations and antitrust policy: some recent issues.
    Costillo LB
    Health Matrix; 1986; 4(2):22-5. PubMed ID: 10278618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perspectives. Antitrust enforcement: reshaping the health system.
    Kent C
    Faulkner Grays Med Health; 1994 Dec; 48(48):suppl 1-4. PubMed ID: 10138740
    [No Abstract]   [Full Text] [Related]  

  • 32. Important changes in antitrust enforcement policy for physician networks.
    J Ark Med Soc; 1996 Nov; 93(6):272-5. PubMed ID: 8961665
    [No Abstract]   [Full Text] [Related]  

  • 33. Preserving antitrust.
    O'Neil-White A; Wilber K
    HMO; 1995; 36(3):15-7. PubMed ID: 10166472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interpreting the 1996 federal antitrust guidelines for physician joint venture networks.
    Hirshfeld E
    Ann Health Law; 1997; 6():1-49. PubMed ID: 10173274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physician-sponsored managed care networks: two suggestions for antitrust reform.
    Bierig JR
    Health Matrix Clevel; 1996; 6(1):115-28. PubMed ID: 10167163
    [No Abstract]   [Full Text] [Related]  

  • 36. The Federal Trade Commission and physician practice.
    Graham J
    J Med Pract Manage; 2005; 20(5):259-62. PubMed ID: 15921139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does your physician network violate antitrust law?. Interview by Michael Pretzer.
    Pitofsky R
    Med Econ; 1996 Oct; 73(19):68-70, 73-6, 79. PubMed ID: 10162456
    [No Abstract]   [Full Text] [Related]  

  • 38. Governmental antitrust policy: soon obsolete?
    Uzych L
    Pa Med; 1994 Jun; 97(6):26-7. PubMed ID: 8065779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrated delivery systems: reforming the conflicts among federal referral, tax exemption, and antitrust laws.
    Woodhall AL
    Health Matrix Clevel; 1995; 5(1):181-248. PubMed ID: 10141744
    [No Abstract]   [Full Text] [Related]  

  • 40. Managed competition, integrated delivery systems and antitrust.
    Greaney TL
    Cornell Law Rev; 1994 Sep; 79(6):1507-45. PubMed ID: 10141442
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.